These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16570682)

  • 1. Role of EDTA chelation therapy in cardiovascular diseases.
    Shrihari JS; Roy A; Prabhakaran D; Reddy KS
    Natl Med J India; 2006; 19(1):24-6. PubMed ID: 16570682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chelation therapy in the treatment of cardiovascular diseases.
    Ibad A; Khalid R; Thompson PD
    J Clin Lipidol; 2016; 10(1):58-62. PubMed ID: 26892121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDTA chelation therapy for cardiovascular disease: a systematic review.
    Seely DM; Wu P; Mills EJ
    BMC Cardiovasc Disord; 2005 Nov; 5():32. PubMed ID: 16262904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelation therapy in cardiovascular disease: an update.
    Sultan S; Murarka S; Jahangir A; Mookadam F; Tajik AJ; Jahangir A
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):843-854. PubMed ID: 28597699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation therapy for atherosclerotic cardiovascular disease.
    Villarruz MV; Dans A; Tan F
    Cochrane Database Syst Rev; 2002; (4):CD002785. PubMed ID: 12519577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation on curative effects of ethylene diamine tetra-acetic acid chelation therapy in treating with atherosclerotic cardiovascular disease: A protocol for systematic review and meta-analysis.
    Song T; Zhang D
    Medicine (Baltimore); 2020 Dec; 99(52):e23346. PubMed ID: 33350725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane.
    Elihu N; Anandasbapathy S; Frishman WH
    J Clin Pharmacol; 1998 Feb; 38(2):101-5. PubMed ID: 9549639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.
    Ouyang P; Gottlieb SH; Culotta VL; Navas-Acien A
    Curr Cardiol Rep; 2015 Nov; 17(11):96. PubMed ID: 26364188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDTA chelation therapy meets evidence-based medicine.
    Lamas GA; Hussein SJ
    Complement Ther Clin Pract; 2006 Aug; 12(3):213-5. PubMed ID: 16835033
    [No Abstract]   [Full Text] [Related]  

  • 10. A TACTful reappraisal of chelation therapy in cardiovascular disease.
    Sidhu MS; Saour BM; Boden WE
    Nat Rev Cardiol; 2014 Mar; 11(3):180-3. PubMed ID: 24343569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation therapy for coronary heart disease: An overview of all clinical investigations.
    Ernst E
    Am Heart J; 2000 Jul; 140(1):139-41. PubMed ID: 10874275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelation therapy for cardiovascular disease. Review and commentary.
    Lewin MR
    Tex Heart Inst J; 1997; 24(2):81-9. PubMed ID: 9205980
    [No Abstract]   [Full Text] [Related]  

  • 13. EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.
    Born T; Kontoghiorghe CN; Spyrou A; Kolnagou A; Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):11-7. PubMed ID: 22991933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EDTA chelation therapy in the treatment of vascular disease.
    Chappell LT; Janson M
    J Cardiovasc Nurs; 1996 Apr; 10(3):78-86. PubMed ID: 8820322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients.
    Peguero JG; Arenas I; Lamas GA
    Trends Cardiovasc Med; 2014 Aug; 24(6):232-40. PubMed ID: 25106084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelation trial in patients with cardiovascular disease.
    Yen TH; Yen JS
    Am Heart J; 2023 Feb; 256():1. PubMed ID: 36336079
    [No Abstract]   [Full Text] [Related]  

  • 17. Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.
    Mathew RO; Schulman-Marcus J; Nichols EL; Newman JD; Bangalore S; Farkouh M; Sidhu MS
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):619-625. PubMed ID: 29129003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.
    Ravalli F; Vela Parada X; Ujueta F; Pinotti R; Anstrom KJ; Lamas GA; Navas-Acien A
    J Am Heart Assoc; 2022 Mar; 11(6):e024648. PubMed ID: 35229619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    Calderon Moreno R; Navas-Acien A; Escolar E; Nathan DM; Newman J; Schmedtje JF; Diaz D; Lamas GA; Fonseca V
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2931-2941. PubMed ID: 30869793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.